
World COPD Day is nearly here, and we are grateful in advance for your help with our first ever global #SpeakUpforCOPD Social Chat.
We will post a sequence of open and poll questions on LinkedIn and Facebook every 15 minutes within each regional time zone, all using the hashtag #SpeakUpforCOPD.
Below are the final details and expectations for how the event will run across time zones, along with moderation guidance for the day.
Time Zone Schedule & Questions
The questions are provided below so you can draft and refine your thoughtful responses in advance. Please familiarize yourself with the questions for your respective region.
What We Need from You
Throughout your assigned hour, please:
1. Engage with every question
- Respond to every question on our Facebook and LinkedIn posts.
- Keep responses warm, welcoming, and aligned with campaign messaging.
2. Actively participate
- Like, comment, and share posts within your own network.
- Share stories, insights, or policy concerns relevant to your region.
You may use the Speak Up for COPD logo when sharing our official campaign posts. However, we strongly discourage creating your own visual content using the Speak Up for COPD logo without prior approval from the GAAPP team, as all such content must be approved by our partners.
3. Promote the campaign hashtag
We encourage you to post every reply including #SpeakUpforCOPD to help amplify the message, increase visibility across platforms, and help us track this campaign’s global impact.
4. Use Native Languages
To broaden our audience reach, we strongly encourage you to post your comments in your native language if it is other than English.
Community Conduct
Please do not post or engage inappropriate comments, including:
- Discriminatory or harassing language
- Political statements
- Product promotion, medical advice, medication discussion, or symptom descriptions
Human Safety Information (HSI) non-compliant content
HSI is any information related to human health and/or well-being following exposure to any pharmaceutical products. HSI is more than just adverse events (AEs). It includes:
- Any unintended sign, symptom, or disease (AE / side effect).
- Lack of efficacy or failure to produce expected benefits.
- Misuse (intentional), abuse, or off-label use.
- Medication errors (such as accidental overdose) or intercepted medication errors.
- AEs associated with a product complaint, like finding small particles in toothpaste.
- Occupational exposure (e.g., a nurse with a needlestick injury).
- Exposure during pregnancy or breastfeeding, and paternal exposure.
- Adverse events associated with falsified medicinal products.
- Unexpected therapeutic benefits.
Why Report HSI? Reporting HSI is crucial for collecting safety information, detecting signals, managing the benefit-risk profile of products, preventing harm, and complying with strict regulatory timelines for communicating safety updates. A single case can lead to product label updates.
How to Report HSI:
- Inform the GAAPP team as soon as you become aware of any HSI.
- You must report HSI within 24 hours of becoming aware of it (or the next working day if it’s during the weekend).
- Try to capture as much information as possible, including details about the Patient, the Reporter, the Event, and the Product (PREP).
- Even if you only have partial information or are in doubt, you must still reach out to the GAAPP team.
Instead, notify our team. We will take care of reporting, hiding, or blocking as appropriate.
Platforms
The social chat will take place simultaneously on:
Please ensure you are logged in, have notifications enabled for GAAPP pages, and are ready a few minutes before your scheduled start time.
Thank you all for helping create a strong, coordinated, and impactful global conversation this World COPD Day! Your participation is key to raising awareness, fighting stigma, and driving attention to COPD on a truly international scale. If you have any questions, please don’t hesitate to reach out to us: .
To be eligible for the GAAPP member organization-exclusive Communication Grant, please refer to the campaign toolkit.
